Bone regeneration using bone morphogenetic proteins and various biomaterial carriers

Materials

Volumn 8, Issue 4, 2015, Pages 1778-1816

  Sheikh, Zeeshan ^a   Javaid, Mohammad Ahmad ^b   Hamdan, Nader ^c   Hashmi, Raheel ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Near South City Hospital   (Pakistan)

Author keywords

Biomaterials; BMPs; Bone morphogenetic proteins; Bone regeneration; Carrier methods

Indexed keywords

BIOMATERIALS; CELL CULTURE; PROTEINS; STEM CELLS;

BMPS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CARRIER METHOD; CLINICAL APPLICATION; MESENCHYMAL STEM CELL; OSTEOGENIC CELLS; RESEARCH GROUPS;

BONE;

EID: 84930628976     PISSN: None     EISSN: 19961944     Source Type: Journal    
DOI: 10.3390/ma8041778     Document Type: Review

References (331)

1. Damien, C.J.; Parsons, J.R. Bone graft and bone graft substitutes: A review of current technology and applications. J. Appl. Biomater. 1991, 2, 187-208.
2. Javaid, M.A.; Kaartinen, M.T. Mesenchymal stem cell-based bone tissue engineering. Int. Dent. J. Stud. Res. 2013, 1, 24-35.
3. Hubble, M.J.W. Bone grafts. Surg. Technol. Int. 2002, 10, 261-265.
4. Sheikh, Z.A.A.; Javaid, M.A.; Abdallah, M.N. Bone replacement graft materials in dentistry. In Dental Biomaterials (Principle and Its Application), 2nd ed.; Khurshid, Z.S.Z., Ed.; Paramount Publishing Enterprise: Karachi, Pakistan, 2013.
5. Cypher, T.J.; Grossman, J.P. Biological principles of bone graft healing. J. Foot Ankle Surg. 1996, 35, 413-417.
6. Heary, R.F.; Schlenk, R.P.; Sacchieri, T.A.; Barone, D.; Brotea, C. Persistent iliac crest donor site pain: Independent outcome assessment. Neurosurgery 2002, 50, 510-516.
7. Ahlmann, E.; Patzakis, M.; Roidis, N.; Shepherd, L.; Holtom, P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J. Bone Jt. Surg. Am. 2002, 84, 716-720.
8. Robertson, P.A.; Wray, A.C. Natural history of posterior iliac crest bone graft donation for spinal surgery: A prospective analysis of morbidity. Spine 2001, 26, 1473-1476.
9. Boden, S.D. The ABCs of BMPs. Orthop. Nurs. 2005, 24, 49-52.
10. Tevlin, R.; McArdle, A.; Atashroo, D.; Walmsley, G.G.; Senarath-Yapa, K.; Zielins, E.R.; Paik, K.J.; Longaker, M.T.; Wan, D.C. Biomaterials for craniofacial bone engineering. J. Dent. Res. 2014, 93, 1187-1195.
11. LeGeros, R.Z. LeGeros. Bone Substitute Materials and Their Properties; Georg Thieme Verlag: Stuttgart, Germany; New York, NY, USA, 1997; pp. 12-18.
12. Arrington, E.D.; Smith, W.J.; Chambers, H.G.; Bucknell, A.L.; Davino, N.A. Complications of iliac crest bone graft harvesting. Clin. Orthop. Relat. Res. 1996, 329, 300-309.
13. Bessa, P.C.; Casal, M.; Reis, R.L. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP delivery). J. Tissue Eng. Regen. Med. 2008, 2, 81-96.
14. Termaat, M.; Den Boer, F.; Bakker, F.; Patka, P.; Haarman, H.T.M. Bone morphogenetic proteins development and clinical efficacy in the treatment of fractures and bone defects. J. Bone Jt. Surg. 2005, 87, 1367-1378.
15. Schmitt, J.M.; Hwang, K.; Winn, S.R.; Hollinger, J.O. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J. Orthop. Res. 1999, 17, 269-278.
16. Reddi, A.H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 1998, 16, 247-252.
17. Bragdon, B.; Moseychuk, O.; Saldanha, S.; King, D.; Julian, J.; Nohe, A. Bone morphogenetic proteins: A critical review. Cell. Signal. 2011, 23, 609-620.
18. Carreira, A.C.; Lojudice, F.H.; Halcsik, E.; Navarro, R.D.; Sogayar, M.C.; Granjeiro, J.M. Bone morphogenetic proteins: Facts, challenges, and future perspectives. J. Dent. Res. 2014, 93, 335-345.
19. Urist, M.R.; Strates, B.S. Bone morphogenetic protein. J. Dent. Res. 1971, 50, 1392-1406.
20. Laurencin, C.T.; Lo, K.W. Bone morphogenetic proteins for bone regeneration and their alternatives. Curr. Pharm. Des. 2013, 19, 3353.
21. Docherty Skogh, A.C.; Engstrand, T. Bone morphogenetic proteins in cranial reconstructions: Clinical evaluation of heparin-chitosan as a carrier for BMP-2. Plast. Reconstr. Surg. 2009, 123, 192e-193e.
22. Chenard, K.E.; Teven, C.M.; He, T.C.; Reid, R.R. Bone morphogenetic proteins in craniofacial surgery: Current techniques, clinical experiences, and the future of personalized stem cell therapy. J. Biomed. Biotechnol. 2012, 2012, 601549:1-601549:14.
23. Argintar, E.; Edwards, S.; Delahay, J. Bone morphogenetic proteins in orthopaedic trauma surgery. Injury 2011, 42, 730-734.
24. Rao, S.M.; Ugale, G.M.; Warad, S.B. Bone morphogenetic proteins: Periodontal regeneration. N. Am. J. Med. Sci. 2013, 5, 161-168.
25. Carreira, A.C.; Alves, G.G.; Zambuzzi, W.F.; Sogayar, M.C.; Granjeiro, J.M. Bone morphogenetic proteins: Structure, biological function and therapeutic applications. Arch. Biochem. Biophys. 2014, 561, 64-73.
26. Granjeiro, J.M.; Oliveira, R.C.; Bustos-Valenzuela, J.C.; Sogayar, M.C.; Taga, R. Bone morphogenetic proteins: From structure to clinical use. Braz. J. Med. Biol. Res. 2005, 38, 1463-1473.
27. Myllyla, R.M.; Haapasaari, K.M.; Lehenkari, P.; Tuukkanen, J. Bone morphogenetic proteins 4 and 2/7 induce osteogenic differentiation of mouse skin derived fibroblast and dermal papilla cells. Cell Tissue Res. 2014, 355, 463-470.
28. Zhang, X.; Guo, J.; Zhou, Y.; Wu, G. The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells. Tissue Eng. B Rev. 2014, 20, 84-92.
29. Rengachary, S.S. Bone morphogenetic proteins: Basic concepts. Neurosurg. Focus 2002, 13, 1-6.
30. Ducy, P.; Karsenty, G. The family of bone morphogenetic proteins. Kidney Int. 2000, 57, 2207-2214.
31. Constam, D.B.; Robertson, E.J. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell Biol. 1999, 144, 139-149.
32. Wordinger, R.J.; Agarwal, R.; Talati, M.; Fuller, J.; Lambert, W.; Clark, A.F. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol. Vis. 2002, 8, 241-250.
33. Yonemori, K.; Imamura, T.; Ishidou, Y.; Okano, T.; Matsunaga, S.; Yoshida, H.; Kato, M.; Sampath, T.K.; Miyazono, K.; Ten Dijke, P. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament. Am. J. Pathol. 1997, 150, 1335-1347.
34. Heldin, C.H.; Miyazono, K.; ten Dijke, P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390, 465-471.
35. Huse, K.; Bakkebø, M.; Wälchli, S.; Oksvold, M.P.; Hilden, V.I.; Forfang, L.; Bredahl, M.L.; Liestøl, K.; Alizadeh, A.A.; Smeland, E.B. Role of smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma. PLoS One 2012, 7, doi:10.1371/journal.pone.0046117.
36. Gautschi, O.P.; Frey, S.P.; Zellweger, R. Bone morphogenetic proteins in clinical applications. ANZ J. Surg. 2007, 77, 626-631.
37. Yamaguchi, A.; Katagiri, T.; Ikeda, T.; Wozney, J.M.; Rosen, V.; Wang, E.A.; Kahn, A.J.; Suda, T.; Yoshiki, S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 1991, 113, 681-687.
38. Thies, R.S.; Bauduy, M.; Ashton, B.A.; Kurtzberg, L.; Wozney, J.M.; Rosen, V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in w-20-17 stromal cells. Endocrinology 1992, 130, 1318-1324.
39. Chen, T.L.; Bates, R.L.; Dudley, A.; Hammonds, R.G., Jr.; Amento, E.P. Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: Comparison with TGF-beta 1. J. Bone Miner. Res. 1991, 6, 1387-1393.
40. Mayer, H.; Scutt, A.M.; Ankenbauer, T. Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins -2 to -7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor. Calcif. Tissue Int. 1996, 58, 249-255.
41. Hughes, F.J.; Collyer, J.; Stanfield, M.; Goodman, S.A. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995, 136, 2671-2677.
42. Cheng, H.; Jiang, W.; Phillips, F.M.; Haydon, R.C.; Peng, Y.; Zhou, L.; Luu, H.H.; An, N.; Breyer, B.; Vanichakarn, P.; et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPS). J. Bone Jt. Surg. Am. 2003, 85, 1544-1552.
43. Kang, Q.; Sun, M.H.; Cheng, H.; Peng, Y.; Montag, A.G.; Deyrup, A.T.; Jiang, W.; Luu, H.H.; Luo, J.; Szatkowski, J.P.; et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004, 11, 1312-1320.
44. Katanec, D.; Granic, M.; Majstorovic, M.; Trampus, Z.; Panduric, D.G. Use of recombinant human bone morphogenetic protein (rhBMP2) in bilateral alveolar ridge augmentation: Case report. Coll. Antropol. 2014, 38, 325-330.
45. Bibbo, C.; Nelson, J.; Ehrlich, D.; Rougeux, B. Bone morphogenetic proteins: Indications and uses. Clin. Podiatr. Med. Surg. 2015, 32, 35-43.
46. Mont, M.A.; Ragland, P.S.; Biggins, B.; Friedlaender, G.; Patel, T.; Cook, S.; Etienne, G.; Shimmin, A.; Kildey, R.; Rueger, D.C. Use of bone morphogenetic proteins for musculoskeletal applicationsan overview. J. Bone Jt. Surg. 2004, 86, 41-55.
47. Cha, J.K.; Lee, J.S.; Kim, M.S.; Choi, S.H.; Cho, K.S.; Jung, U.W. Sinus augmentation using BMP-2 in a bovine hydroxyapatite/collagen carrier in dogs. J. Clin. Periodontol. 2014, 41, 86-93.
48. Martinez-Sanz, E.; Alkhraisat, M.H.; Paradas, I.; Lopez, Y.; Maldonado, E.; Gonzalez-Meli, B.; Berenguer, B.; Lopez-Cabarcos, E.; Martinez, M.L.; Martinez-Alvarez, C. Osteoinduction in the palatal submucosa by injecting BMP-2 on 2 different carriers. J. Craniofac. Surg. 2012, 23, 594-598.
49. Kempen, D.H.; Yaszemski, M.J.; Heijink, A.; Hefferan, T.E.; Creemers, L.B.; Britson, J.; Maran, A.; Classic, K.L.; Dhert, W.J.; Lu, L. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. J. Control. Release 2009, 134, 169-176.
50. Gruber, R.M.; Krohn, S.; Mauth, C.; Dard, M.; Molenberg, A.; Lange, K.; Perske, C.; Schliephake, H. Mandibular reconstruction using a calcium phosphate/polyethylene glycol hydrogel carrier with BMP-2. J. Clin. Periodontol. 2014, 41, 820-826.
51. Osidak, E.O.; Osidak, M.S.; Sivogrivov, D.E.; Portnaya, T.S.; Grunina, T.M.; Galushkina, Z.M.; Lunin, V.G.; Karyagina, A.S.; Domogatskii, S.P. Kinetics of BMP-2 release from collagen carrier: Evaluation by enzyme immunoassay in the presence of plasma proteins. Bull. Exp. Biol. Med. 2014, 158, 104-108.
52. Ansari, S.; Freire, M.O.; Pang, E.K.; Abdelhamid, A.I.; Almohaimeed, M.; Zadeh, H.H. Immobilization of murine anti-BMP-2 monoclonal antibody on various biomaterials for bone tissue engineering. BioMed. Res. Int. 2014, 2014, doi:10.1155/2014/940860.
53. Xie, G.; Sun, J.; Zhong, G.; Liu, C.; Wei, J. Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: Absorption and release kinetics in vitro. J. Mater. Sci. Mater. Med. 2010, 21, 1875-1880.
54. Horasawa, N.; Yamashita, T.; Uehara, S.; Udagawa, N. High-performance scaffolds on titanium surfaces: Osteoblast differentiation and mineralization promoted by a globular fibrinogen layer through cell-autonomous BMP signaling. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 46, 86-96.
55. Hulsart-Billstrom, G.; Hu, Q.; Bergman, K.; Jonsson, K.B.; Aberg, J.; Tang, R.; Larsson, S.; Hilborn, J. Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: A study on ectopic bone formation in rats. Acta Biomater. 2011, 7, 3042-3049.
56. Jun, S.H.; Lee, E.J.; Jang, T.S.; Kim, H.E.; Jang, J.H.; Koh, Y.H. Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering. J. Mater. Sci. Mater. Med. 2013, 24, 773-782.
57. Ji, Y.; Xu, G.P.; Zhang, Z.P.; Xia, J.J.; Yan, J.L.; Pan, S.H. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann. Biomed. Eng. 2010, 38, 632-639.
58. Kempen, D.H.; Lu, L.; Hefferan, T.E.; Creemers, L.B.; Maran, A.; Classic, K.L.; Dhert, W.J.; Yaszemski, M.J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008, 29, 3245-3252.
59. Murakami, N.; Saito, N.; Takahashi, J.; Ota, H.; Horiuchi, H.; Nawata, M.; Okada, T.; Nozaki, K.; Takaoka, K. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 2003, 24, 2153-2159.
60. Sohier, J.; Daculsi, G.; Sourice, S.; de Groot, K.; Layrolle, P. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J. Biomed. Mater. Res. A 2010, 92, 1105-1114.
61. Kessler, E.; Takahara, K.; Biniaminov, L.; Brusel, M.; Greenspan, D.S. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 1996, 271, 360-362.
62. Zhang, H.; Bradley, A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122, 2977-2986.
63. Bostrom, M.P.; Lane, J.M.; Berberian, W.S.; Missri, A.A.; Tomin, E.; Weiland, A.; Doty, S.B.; Glaser, D.; Rosen, V.M. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J. Orthop. Res. 1995, 13, 357-367.
64. Bahamonde, M.E.; Lyons, K.M. BMP3: To be or not to be a BMP. J. Bone Jt. Surg. Ser. A 2001, 83, S56-S62.
65. Cunningham, N.S.; Jenkins, N.A.; Gilbert, D.J.; Copeland, N.G.; Reddi, A.H.; Lee, S.J. Growth/differentiation factor-10: A new member of the transforming growth factor-β superfamily related to bone morphogenetic protein-3. Growth Factors 1995, 12, 99-109.
66. Ten Dijke, P.; Yamashita, H.; Sampath, T.K.; Reddi, A.H.; Estevez, M.; Riddle, D.L.; Ichijo, H.; Heldin, C.H.; Miyazono, K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 1994, 269, 16985-16988.
67. Xu, P.X.; Zheng, W.; Huang, L.; Maire, P.; Laclef, C.; Silvius, D. Six1 is required for the early organogenesis of mammalian kidney. Development 2003, 130, 3085-3094.
68. Winnier, G.; Blessing, M.; Labosky, P.A.; Hogan, B.L.M. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995, 9, 2105-2116.
69. Ro, T.B.; Holt, R.U.; Brenne, A.T.; Hjorth-Hansen, H.; Waage, A.; Hjertner, O.; Sundan, A.; Borset, M. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004, 23, 3024-3032.
70. King, J.A.; Marker, P.C.; Seung, K.J.; Kingsley, D.M. BMP5 and the molecular, skeletal, and soft-tissue alterations in short ear mice. Dev. Biol. 1994, 166, 112-122.
71. Nonner, D.; Barrett, E.F.; Kaplan, P.; Barrett, J.N. Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia. J. Neurochem. 2001, 77, 691-699.
72. Hahn, G.V.; Cohen, R.B.; Wozney, J.M.; Levitz, C.L.; Shore, E.M.; Zasloff, M.A.; Kaplan, F.S. A bone morphogenetic protein subfamily: Chromosomal localization of human genes for BMP5, BMP6, and BMP7. Genomics 1992, 14, 759-762.
73. Zhang, Y.; Ge, G.; Greenspan, D.S. Inhibition of bone morphogenetic protein 1 by native and altered forms of α2-macroglobulin. J. Biol. Chem. 2006, 281, 39096-39104.
74. Dudley, A.T.; Lyons, K.M.; Robertson, E.J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 1995, 9, 2795-2807.
75. Nakase, T.; Yoshikawa, H. Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration. J. Bone Miner. Metab. 2006, 24, 425-433.
76. Zhao, G.Q.; Hogan, B.L.M. Evidence that mouse BMP8α (op2) and BMP8b are duplicated genes that play a role in spermatogenesis and placental development. Mech. Dev. 1996, 57, 159-168.
77. David, L.; Mallet, C.; Mazerbourg, S.; Feige, J.J.; Bailly, S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007, 109, 1953-1961.
78. Nakashima, M.; Tachibana, K.; Iohara, K.; Ito, M.; Ishikawa, M.; Akamine, A. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum. Gene Ther. 2003, 14, 591-597.
79. Furuya, K.; Nifuji, A.; Rosen, V.; Noda, M. Effects of GDF7/BMP12 on proliferation and alkaline phosphatase expression in rat osteoblastic osteosarcoma ROS 17/2.8 cells. J. Cell. Biochem. 1999, 72, 177-180.
80. Nochi, H.; Jin, H.S.; Lou, J.; Adkisson, H.D.; Maloney, W.J.; Hruska, K.A. Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J. Bone Miner. Res. 2004, 19, 111-122.
81. Wolfman, N.M.; Hattersley, G.; Cox, K.; Celeste, A.J.; Nelson, R.; Yamaji, N.; Dube, J.L.; DiBlasio-Smith, E.; Nove, J.; Song, J.J.; et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J. Clin. Investig. 1997, 100, 321-330.
82. Di Pasquale, E.; Rossetti, R.; Marozzi, A.; Bodega, B.; Borgato, S.; Cavallo, L.; Einaudi, S.; Radetti, G.; Russo, G.; Sacco, M.; et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J. Clin. Endocrinol. Metab. 2006, 91, 1976-1979.
83. Feiner, N.; Begemann, G.; Renz, A.J.; Meyer, A.; Kuraku, S. The origin of BMP16, a novel BMP2/4 relative, retained in teleost fish genomes. BMC Evolut. Biol. 2009, 9, 277.
84. Celeste, A.J.; Murray, B.L. Bone Morphogenetic Protein (BMP)-17 and BMP-18 Compositions. U.S. Patent 6027917 A, 1 January 2002.
85. Chen, D.; Zhao, M.; Mundy, G.R. Bone morphogenetic proteins. Growth Factors 2004, 22, 233-241.
86. Bessa, P.C.; Casal, M.; Reis, R.L. Bone morphogenetic proteins in tissue engineering: The road from the laboratory to the clinic, part I (basic concepts). J. Tissue Eng. Regen. Med. 2008, 2, 1-13.
87. Groeneveld, E.; Burger, E. Bone morphogenetic proteins in human bone regeneration. Eur. J. Endocrinol. 2000, 142, 9-21.
88. Issa, J.P.; Bentley, M.V.; Iyomasa, M.M.; Sebald, W.; de Albuquerque, R.F. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process. Anat. Histol. Embryol. 2008, 37, 181-187.
89. David, L.; Feige, J.J.; Bailly, S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 2009, 20, 203-212.
90. Degat, M.C.; Ferreira, E.; Logeart-Avramoglou, D. Use of growth factors in the repair of bone. Pathologie-Biologie 2005, 53, 131-141.
91. Wikesjo, U.M.; Xiropaidis, A.V.; Thomson, R.C.; Cook, A.D.; Selvig, K.A.; Hardwick, W.R. Periodontal repair in dogs: rhBMP-2 significantly enhances bone formation under provisions for guided tissue regeneration. J. Clin. Periodontol. 2003, 30, 705-714.
92. Lippman, C.R.; Hajjar, M.; Abshire, B.; Martin, G.; Engelman, R.W.; Cahill, D.W. Cervical spine fusion with bioabsorbable cages. Neurosurg. Focus 2004, 16, E4.
93. Blunk, T.; Sieminski, A.L.; Appel, B.; Croft, C.; Courter, D.L.; Chieh, J.J.; Goepferich, A.; Khurana, J.S.; Gooch, K.J. Bone morphogenetic protein 9: A potent modulator of cartilage development in vitro. Growth Factors 2003, 21, 71-77.
94. Zheng, Y.X.; Zhao, H.Y.; Jing, X.B.; Qin, Q.L.; Gu, J.J.; Tian, N.; Huang, D.P. Reconstruction of orbital floor defect with polylacticglycolide acid/recombinant human bone morphogenetic protein 2 compound implanted material in sheep. Chin. J. Ophthalmol. 2006, 42, 535-539.
95. Pan, Z.X.; Zhang, H.X.; Wang, Y.X.; Zhai, L.D.; Du, W. Effect of recombinant human bone morphogenetic protein 2/poly-lactide-co-glycolic acid (rhBMP-2/PLGA) with core decompression on repair of rabbit femoral head necrosis. Asian Pac. J. Trop. Med. 2014, 7, 895-899.
96. Qiao, C.; Zhang, K.; Jin, H.; Miao, L.; Shi, C.; Liu, X.; Yuan, A.; Liu, J.; Li, D.; Zheng, C.; et al. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Int. J. Nanomed. 2013, 8, 2985-2995.
97. Jones, A.A.; Buser, D.; Schenk, R.; Wozney, J.; Cochran, D.L. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J. Periodontol. 2006, 77, 1184-1193.
98. Shimazu, C.; Hara, T.; Kinuta, Y.; Moriya, K.; Maruo, Y.; Hanada, S.; Minagi, S. Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats. J. Oral Rehabil. 2006, 33, 609-618.
99. Hu, J.J.; Jin, D.; Quan, D.P.; Zhong, S.Z.; Chen, J.H.; Wei, K.H.; Zhao, J.; Pei, G.X. Bone defect repair with a new tissue-engineered bone carrying bone morphogenetic protein in rabbits. Acad. J. First Med. Coll. PLA 2005, 25, 1369-1374.
100. Mayer, M.; Hollinger, J.; Ron, E.; Wozney, J. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast. Reconstr. Surg. 1996, 98, 247-259.
101. Kokubo, S.; Fujimoto, R.; Yokota, S.; Fukushima, S.; Nozaki, K.; Takahashi, K.; Miyata, K. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model. Biomaterials 2003, 24, 1643-1651.
102. Han, F.; Zhou, F.; Yang, X.; Zhao, J.; Zhao, Y.; Yuan, X. A pilot study of conically graded chitosan-gelatin hydrogel/PLGA scaffold with dual-delivery of TGF-β1 and BMP-2 for regeneration of cartilage-bone interface. J. Biomed. Mater. Res. Part B Appl. Biomater. 2014, doi:10.1002/jbm.b.33314.
103. Kawamoto, T.; Motohashi, N.; Kitamura, A.; Baba, Y.; Suzuki, S.; Kuroda, T. Experimental tooth movement into bone induced by recombinant human bone morphogenetic protein-2. Cleft Palate-Craniofac. J. 2003, 40, 538-543.
104. Fan, Z.; Cao, Y.; Zhang, Z.; Zhang, M.; Lu, W.; Tang, L.; Yao, Q.; Lu, G. Experimental study on application recombinant human bone morphogenetic protein 2(rhBMP-2)/poly-lactide-co-glycolic acid (PLGA)/fibrin sealant(FS) on repair of rabbit radial bone defect. J. Biomed. Eng. 2012, 29, 903-907. (In Chinese).
105. Jeon, O.; Song, S.J.; Kang, S.W.; Putnam, A.J.; Kim, B.S. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials 2007, 28, 2763-2771.
106. He, X.B.; Lu, W.Z.; Tang, K.L.; Yang, L.; He, J.; Zhu, Q.H.; Liu, X.D.; Xu, J.Z. Effects of bone morphogenetic protein and transforming growth fractor-beta on biomechanical property for fracture healing in rabbit ulna. Chin. J. Reparative Reconstr. Surg. 2003, 17, 185-188. (In Chinese).
107. Hao, W.; Dong, J.; Jiang, M.; Wu, J.; Cui, F.; Zhou, D. Enhanced bone formation in large segmental radial defects by combining adipose-derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffold. Int. Orthop. 2010, 34, 1341-1349.
108. Chang, P.C.; Liu, B.Y.; Liu, C.M.; Chou, H.H.; Ho, M.H.; Liu, H.C.; Wang, D.M.; Hou, L.T. Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds. J. Biomed. Mater. Res. A 2007, 81, 771-780.
109. Tian, W.; Bao, C.; Liu, L.; Tang, W.; Zheng, X.; Li, S.; Xiong, C. Experimental study on the fabrication of bioactive membrane for inducing bone regeneration. J. Biomed. Eng. 2004, 21, 844-847. (In Chinese).
110. Ji, Y.; Xu, G.P.; Yan, J.L.; Pan, S.H. Transplanted bone morphogenetic protein/poly(lactic-co-glycolic acid) delayed-release microcysts combined with rat micromorselized bone and collagen for bone tissue engineering. J. Int. Med. Res. 2009, 37, 1075-1087.
111. Murakami, M.; Ohtake, T.; Dorschner, R.; Gallo, R. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res. 2002, 81, 845-850.
112. Suzuki, Y.; Tanihara, M.; Suzuki, K.; Saitou, A.; Sufan, W.; Nishimura, Y. Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. J. Biomed. Mater. Res. 2000, 50, 405-409.
113. Kato, M.; Namikawa, T.; Terai, H.; Hoshino, M.; Miyamoto, S.; Takaoka, K. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. Biomaterials 2006, 27, 3927-3933.
114. Lutolf, M.P.; Lauer-Fields, J.L.; Schmoekel, H.G.; Metters, A.T.; Weber, F.E.; Fields, G.B.; Hubbell, J.A. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc. Natl. Acad. Sci. USA 2003, 100, 5413-5418.
115. Lutolf, M.P.; Weber, F.E.; Schmoekel, H.G.; Schense, J.C.; Kohler, T.; Muller, R.; Hubbell, J.A. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 2003, 21, 513-518.
116. Rizzi, S.C.; Ehrbar, M.; Halstenberg, S.; Raeber, G.P.; Schmoekel, H.G.; Hagenmuller, H.; Muller, R.; Weber, F.E.; Hubbell, J.A. Recombinant protein-co-peg networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: Biofunctional characteristics. Biomacromolecules 2006, 7, 3019-3029.
117. Kinard, L.A.; Chu, C.Y.; Tabata, Y.; Kasper, F.K.; Mikos, A.G. Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin. Pharm. Res. 2013, 30, 2332-2343.
118. Pratt, A.B.; Weber, F.E.; Schmoekel, H.G.; Muller, R.; Hubbell, J.A. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol. Bioeng. 2004, 86, 27-36.
119. Gao, T.; Uludag, H. Effect of molecular weight of thermoreversible polymer on in vivo retention of rhBMP-2. J. Biomed. Mater. Res. 2001, 57, 92-100.
120. Schmoekel, H.; Schense, J.C.; Weber, F.E.; Gratz, K.W.; Gnagi, D.; Muller, R.; Hubbell, J.A. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J. Orthop. Res. 2004, 22, 376-381.
121. Schmoekel, H.G.; Weber, F.E.; Hurter, K.; Schense, J.C.; Seiler, G.; Ryrz, U.; Spreng, D.; Schawalder, P.; Hubbell, J. Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. J. Small Anim. Pract. 2005, 46, 17-21.
122. Schmoekel, H.G.; Weber, F.E.; Schense, J.C.; Gratz, K.W.; Schawalder, P.; Hubbell, J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol. Bioeng. 2005, 89, 253-262.
123. Zhu, S.J.; Choi, B.H.; Huh, J.Y.; Jung, J.H.; Kim, B.Y.; Lee, S.H. A comparative qualitative histological analysis of tissue-engineered bone using bone marrow mesenchymal stem cells, alveolar bone cells, and periosteal cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006, 101, 164-169.
124. Zhu, S.J.; Choi, B.H.; Jung, J.H.; Lee, S.H.; Huh, J.Y.; You, T.M.; Lee, H.J.; Li, J. A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006, 102, 175-179.
125. Arnander, C.; Westermark, A.; Veltheim, R.; Docherty-Skogh, A.C.; Hilborn, J.; Engstrand, T. Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction. J. Craniofac. Surg. 2006, 17, 275-279.
126. Cui, G.; Li, J.; Lei, W. Effect of injectable fibrin sealant compounded with bone morphogenetic protein on proliferation and differentiation of marrow stromal cells towards osteoblasts in rabbits. Chin. J. Reparative Reconstr. Surg. 2007, 21, 70-75. (In Chinese).
127. Patel, V.V.; Zhao, L.; Wong, P.; Kanim, L.; Bae, H.W.; Pradhan, B.B.; Delamarter, R.B. Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue. Spine 2006, 31, 1201-1206.
128. Yang, H.S.; La, W.G.; Cho, Y.M.; Shin, W.; Yeo, G.D.; Kim, B.S. Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration. Exp. Mol. Med. 2012, 44, 350-355.
129. Hong, J.Y.; Kang, S.W.; Kim, J.W.; Suh, S.W.; Ko, Y.J.; Park, J.H. Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model. Cytotherapy 2014, doi:10.1016/j.jcyt.2014.04.005.
130. Koo, K.H.; Lee, J.M.; Ahn, J.M.; Kim, B.S.; La, W.G.; Kim, C.S.; Im, G.I. Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits. Artif. Organs 2013, 37, 487-494.
131. Hong, L.; Tabata, Y.; Yamamoto, M.; Miyamoto, S.; Yamada, K.; Hashimoto, N.; Ikada, Y. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. J. Biomater. Sci. Polym. Ed. 1998, 9, 1001-1014.
132. Takahashi, Y.; Yamamoto, M.; Yamada, K.; Kawakami, O.; Tabata, Y. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng. 2007, 13, 293-300.
133. Yamamoto, M.; Ikada, Y.; Tabata, Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J. Biomater. Sci. Polym. Ed. 2001, 12, 77-88.
134. Yamamoto, M.; Takahashi, Y.; Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003, 24, 4375-4383.
135. Bulpitt, P.; Aeschlimann, D. New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J. Biomed. Mater. Res. 1999, 47, 152-169.
136. Hulsart-Billstrom, G.; Yuen, P.K.; Marsell, R.; Hilborn, J.; Larsson, S.; Ossipov, D. Bisphosphonate-linked hyaluronic acid hydrogel sequesters and enzymatically releases active bone morphogenetic protein-2 for induction of osteogenic differentiation. Biomacromolecules 2013, 14, 3055-3063.
137. Arosarena, O.; Collins, W. Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses. Orthod. Craniofac. Res. 2005, 8, 267-276.
138. Arosarena, O.A.; Collins, W.L. Bone regeneration in the rat mandible with bone morphogenetic protein-2: A comparison of two carriers. Otolaryngol. Head Neck Surg. 2005, 132, 592-597.
139. Hunt, D.R.; Jovanovic, S.A.; Wikesjo, U.M.; Wozney, J.M.; Bernard, G.W. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J. Periodontol. 2001, 72, 651-658.
140. Seeherman, H.J.; Bouxsein, M.; Kim, H.; Li, R.; Li, X.J.; Aiolova, M.; Wozney, J.M. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J. Bone Jt. Surg. Am. 2004, 86, 1961-1972.
141. Eckardt, H.; Christensen, K.S.; Lind, M.; Hansen, E.S.; Hall, D.W.; Hvid, I. Recombinant human bone morphogenetic protein 2 enhances bone healing in an experimental model of fractures at risk of non-union. Injury 2005, 36, 489-494.
142. Vogelin, E.; Jones, N.F.; Huang, J.I.; Brekke, J.H.; Lieberman, J.R. Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. J. Bone Jt. Surg. Am. 2005, 87, 1323-1331.
143. Karageorgiou, V.; Tomkins, M.; Fajardo, R.; Meinel, L.; Snyder, B.; Wade, K.; Chen, J.; Vunjak-Novakovic, G.; Kaplan, D.L. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J. Biomed. Mater. Res. A 2006, 78, 324-334.
144. Karageorgiou, V.; Meinel, L.; Hofmann, S.; Malhotra, A.; Volloch, V.; Kaplan, D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J. Biomed. Mater. Res. A 2004, 71, 528-537.
145. Li, C.; Vepari, C.; Jin, H.J.; Kim, H.J.; Kaplan, D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006, 27, 3115-3124.
146. Kirker-Head, C.; Karageorgiou, V.; Hofmann, S.; Fajardo, R.; Betz, O.; Merkle, H.P.; Hilbe, M.; von Rechenberg, B.; McCool, J.; Abrahamsen, L.; et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 2007, 41, 247-255.
147. Simmons, C.A.; Alsberg, E.; Hsiong, S.; Kim, W.J.; Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004, 35, 562-569.
148. Saito, A.; Suzuki, Y.; Ogata, S.; Ohtsuki, C.; Tanihara, M. Accelerated bone repair with the use of a synthetic BMP-2-derived peptide and bone-marrow stromal cells. J. Biomed. Mater. Res. A 2005, 72, 77-82.
149. Saito, A.; Suzuki, Y.; Ogata, S.; Ohtsuki, C.; Tanihara, M. Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J. Biomed. Mater. Res. A 2004, 70, 115-121.
150. Saito, A.; Suzuki, Y.; Kitamura, M.; Ogata, S.; Yoshihara, Y.; Masuda, S.; Ohtsuki, C.; Tanihara, M. Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alpha-tricalcium phosphate scaffold. J. Biomed. Mater. Res. A 2006, 77, 700-706.
151. Lopez-Lacomba, J.L.; Garcia-Cantalejo, J.M.; Sanz Casado, J.V.; Abarrategi, A.; Correas Magana, V.; Ramos, V. Use of rhBMP-2 activated chitosan films to improve osseointegration. Biomacromolecules 2006, 7, 792-798.
152. Park, Y.J.; Kim, K.H.; Lee, J.Y.; Ku, Y.; Lee, S.J.; Min, B.M.; Chung, C.P. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol. Appl. Biochem. 2006, 43, 17-24.
153. Yang, X.; Han, G.; Pang, X.; Fan, M. Chitosan/collagen scaffold containing bone morphogenetic protein-7 DNA supports dental pulp stem cell differentiation in vitro and in vivo. J. Biomed. Mater. Res. A 2012, doi:10.1002/jbm.a.34064.
154. Park, D.J.; Choi, B.H.; Zhu, S.J.; Huh, J.Y.; Kim, B.Y.; Lee, S.H. Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites. J. Cranio-maxillo-fac. Surg. 2005, 33, 50-54.
155. Liang, D.; Zuo, A.; Wang, B.; Zhang, J. In vitro osteogenesis of the compound of chitosan and recombinant human bone morphogenetic protein 2. Chin. J. Reparative Reconstr. Surg. 2005, 19, 721-724. (In Chinese).
156. Maire, M.; Chaubet, F.; Mary, P.; Blanchat, C.; Meunier, A.; Logeart-Avramoglou, D. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Biomaterials 2005, 26, 5085-5092.
157. Sumner, D.R.; Turner, T.M.; Urban, R.M.; Virdi, A.S.; Inoue, N. Additive enhancement of implant fixation following combined treatment with rhTGF-β2 and rhBMP-2 in a canine model. J. Bone Jt. Surg. Am. 2006, 88, 806-817.
158. Becker, J.; Kirsch, A.; Schwarz, F.; Chatzinikolaidou, M.; Rothamel, D.; Lekovic, V.; Laub, M.; Jennissen, H.P. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin. Oral Investig. 2006, 10, 217-224.
159. Stenport, V.F.; Johansson, C.; Heo, S.J.; Aspenberg, P.; Albrektsson, T. Titanium implants and BMP-7 in bone: An experimental model in the rabbit. J. Mater. Sci. Mater. Med. 2003, 14, 247-254.
160. Sun, S.X.; Guo, H.H.; Zhang, J.; Yu, B.; Sun, K.N.; Jin, Q.H. BMP-2 and titanium particles synergistically activate osteoclast formation. Braz. J. Med. Biol. Res. 2014, 47, 461-469.
161. Jensen, O.T.; Lehman, H.; Ringeman, J.L.; Casap, N. Fabrication of printed titanium shells for containment of BMP-2 composite graft materials for alveolar bone reconstruction. Int. J. Oral Maxillofac. Implant. 2014, 29, e103-e105.
162. Sachse, A.; Wagner, A.; Keller, M.; Wagner, O.; Wetzel, W.D.; Layher, F.; Venbrocks, R.A.; Hortschansky, P.; Pietraszczyk, M.; Wiederanders, B.; et al. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 2005, 37, 699-710.
163. Bae, S.E.; Choi, J.; Joung, Y.K.; Park, K.; Han, D.K. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface. J. Control. Release 2012, 160, 676-684.
164. Yang, D.H.; Lee, D.; Kwon, Y.; Kim, H.J.; Chun, H.J.; Jang, J.W.; Khang, G. Surface modification of titanium with hydroxyapatite-heparin-BMP-2 enhances the efficacy of bone formation and osseointegration in vitro and in vivo. J. Tissue Eng. Regen. Med.2014, doi:10.1002/term.1973.
165. Poth, N.; Seiffart, V.; Gross, G.; Menzel, H.; Dempwolf, W. Biodegradable chitosan nanoparticle coatings on titanium for the delivery of BMP-2. Biomolecules 2015, 5, 3-19.
166. Phillips, F.M.; Turner, A.S.; Seim, H.B., 3rd; MacLeay, J.; Toth, C.A.; Pierce, A.R.; Wheeler, D.L. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J. 2006, 6, 500-506.
167. Schrier, J.A.; Fink, B.F.; Rodgers, J.B.; Vasconez, H.C.; DeLuca, P.P. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing. AAPS PharmSciTech 2001, 2, E18.
168. Oldham, J.B.; Lu, L.; Zhu, X.; Porter, B.D.; Hefferan, T.E.; Larson, D.R.; Currier, B.L.; Mikos, A.G.; Yaszemski, M.J. Biological activity of rhBMP-2 released from PLGA microspheres. J. Biomech. Eng. 2000, 122, 289-292.
169. Lee, S.Y.; Yun, Y.P.; Song, H.R.; Chun, H.J.; Yang, D.H.; Park, K.; Kim, S.E. The effect of titanium with heparin/BMP-2 complex for improving osteoblast activity. Carbohydr. Polym. 2013, 98, 546-554.
170. Kenley, R.; Marden, L.; Turek, T.; Jin, L.; Ron, E.; Hollinger, J.O. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Biomed. Mater. Res. 1994, 28, 1139-1147.
171. Ruhe, P.Q.; Boerman, O.C.; Russel, F.G.; Spauwen, P.H.; Mikos, A.G.; Jansen, J.A. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J. control. Release 2005, 106, 162-171.
172. Ruhe, P.Q.; Boerman, O.C.; Russel, F.G.; Mikos, A.G.; Spauwen, P.H.; Jansen, J.A. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J. Mater. Sci. Mater. Med. 2006, 17, 919-927.
173. Saitoh, H.; Takata, T.; Nikai, H.; Shintani, H.; Hyon, S.H.; Ikada, Y. Effect of polylactic acid on osteoinduction of demineralized bone: Preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein. J. Oral Rehabil. 1994, 21, 431-438.
174. Xu, X.; Yang, J.; Ding, L.; Li, J. Bone morphogenetic protein-2-encapsulated grafted-poly-lactic acid-polycaprolactone nanoparticles promote bone repair. Cell Biochem. Biophys. 2015, 71, 215-225.
175. Wang, Y.J.; Lin, F.H.; Sun, J.S.; Huang, Y.C.; Chueh, S.C.; Hsu, F.Y. Collagen-hydroxyapatite microspheres as carriers for bone morphogenic protein-4. Artif. Organs 2003, 27, 162-168.
176. Murphy, C.M.; Schindeler, A.; Gleeson, J.P.; Yu, N.Y.; Cantrill, L.C.; Mikulec, K.; Peacock, L.; O'Brien, F.J.; Little, D.G. A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates. Acta Biomater. 2014, 10, 2250-2258.
177. Hannink, G.; Geutjes, P.J.; Daamen, W.F.; Buma, P. Evaluation of collagen/heparin coated tcp/ha granules for long-term delivery of BMP-2. J. Mater. Sci. Mater. Med. 2013, 24, 325-332.
178. Itoh, S.; Matubara, M.; Kawauchi, T.; Nakamura, H.; Yukitake, S.; Ichinose, S.; Shinomiya, K. Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid. J. Mater. Sci. Mater. Med. 2001, 12, 575-581.
179. Chen, W.; Liu, Z.; Yue, Y.; Wan, L.; Hu, J.; Lu, B. Preparation of basic fibroblast growth factor chitosan microsphere and its properties. Chin. J. Reparative Reconstr. Surg. 2012, 26, 989-992. (In Chinese).
180. Chen, F.M.; Wu, Z.F.; Sun, H.H.; Wu, H.; Xin, S.N.; Wang, Q.T.; Dong, G.Y.; Ma, Z.W.; Huang, S.; Zhang, Y.J.; et al. Release of bioactive BMP from dextran-derived microspheres: A novel delivery concept. Int. J. Pharm. 2006, 307, 23-32.
181. Chen, F.M.; Zhao, Y.M.; Zhang, R.; Jin, T.; Sun, H.H.; Wu, Z.F.; Jin, Y. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J. Control. Release 2007, 121, 81-90.
182. Qin, Y.; Pei, G.X.; Xie, D.M.; Jin, D.; Wei, K.H. Effect of bone morphogenetic protein microspheres on biological behavior of rabbit bone marrow stem cells. Acad. J. First Med. Coll. PLA 2003, 23, 1021-1024.
183. Aebli, N.; Stich, H.; Schawalder, P.; Theis, J.C.; Krebs, J. Effects of bone morphogenetic protein-2 and hyaluronic acid on the osseointegration of hydroxyapatite-coated implants: An experimental study in sheep. J. Biomed. Mater. Res. A 2005, 73, 295-302.
184. Zhang, C.; Hu, Y.; Xiong, Z.; Zhang, S.; Yan, Y.; Cui, F. Tissue engineered bone regeneration of periosteal cells using recombinant human bone morphogenetic protein 2 induce. Chin. J. Reparative Reconstr. Surg. 2005, 19, 100-104. (In Chinese).
185. Hu, Y.Y.; Zhang, C.; Lu, R.; Xu, J.Q.; Li, D. Repair of radius defect with bone-morphogenetic-protein loaded hydroxyapatite/collagen-poly(L-lactic acid) composite. Chin. J. Traumatol. 2003, 6, 67-74.
186. Kaito, T.; Myoui, A.; Takaoka, K.; Saito, N.; Nishikawa, M.; Tamai, N.; Ohgushi, H.; Yoshikawa, H. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 2005, 26, 73-79.
187. Yoneda, M.; Terai, H.; Imai, Y.; Okada, T.; Nozaki, K.; Inoue, H.; Miyamoto, S.; Takaoka, K. Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant. Biomaterials 2005, 26, 5145-5152.
188. Matsushita, N.; Terai, H.; Okada, T.; Nozaki, K.; Inoue, H.; Miyamoto, S.; Takaoka, K. A new bone-inducing biodegradable porous beta-tricalcium phosphate. J. Biomed. Mater. Res. A 2004, 70, 450-458.
189. Namikawa, T.; Terai, H.; Suzuki, E.; Hoshino, M.; Toyoda, H.; Nakamura, H.; Miyamoto, S.; Takahashi, N.; Ninomiya, T.; Takaoka, K. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine 2005, 30, 1717-1722.
190. Hong, S.J.; Kim, C.S.; Han, D.K.; Cho, I.H.; Jung, U.W.; Choi, S.H.; Kim, C.K.; Cho, K.S. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 2006, 27, 3810-3816.
191. Sun, X.J.; Xia, L.G.; Chou, L.L.; Zhong, W.; Zhang, X.L.; Wang, S.Y.; Zhao, J.; Jiang, X.Q.; Zhang, Z.Y. Maxillary sinus floor elevation using a tissue engineered bone complex with BMP-2 gene modified bmscs and a novel porous ceramic scaffold in rabbits. Arch. Oral Biol. 2010, 55, 195-202.
192. Abarrategi, A.; Moreno-Vicente, C.; Martinez-Vazquez, F.J.; Civantos, A.; Ramos, V.; Sanz-Casado, J.V.; Martinez-Corria, R.; Perera, F.H.; Mulero, F.; Miranda, P.; et al. Biological properties of solid free form designed ceramic scaffolds with BMP-2: In vitro and in vivo evaluation. PLoS One 2012, 7, doi:10.1371/journal.pone.0034117.
193. Roldan, J.C.; Detsch, R.; Schaefer, S.; Chang, E.; Kelantan, M.; Waiss, W.; Reichert, T.E.; Gurtner, G.C.; Deisinger, U. Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model. J. Cranio-Maxillo-Fac. Surg. 2010, 38, 423-430.
194. Schopper, C.; Moser, D.; Spassova, E.; Goriwoda, W.; Lagogiannis, G.; Hoering, B.; Ewers, R.; Redl, H. Bone regeneration using a naturally grown ha/tcp carrier loaded with rh BMP-2 is independent of barrier-membrane effects. J. Biomed. Mater. Res. A 2008, 85, 954-963.
195. Crouzier, T.; Sailhan, F.; Becquart, P.; Guillot, R.; Logeart-Avramoglou, D.; Picart, C. The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating. Biomaterials 2011, 32, 7543-7554.
196. Tamimi, F.; Sheikh, Z.; Barralet, J. Dicalcium phosphate cements: Brushite and monetite. Acta Biomater. 2012, 8, 474-487.
197. Woodard, J.R.; Hilldore, A.J.; Lan, S.K.; Park, C.J.; Morgan, A.W.; Eurell, J.A.; Clark, S.G.; Wheeler, M.B.; Jamison, R.D.; Wagoner Johnson, A.J. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 2007, 28, 45-54.
198. LeGeros, R.Z. Properties of osteoconductive biomaterials: Calcium phosphates. Clin. Orthop. Relat. Res. 2002, 395, 81-98.
199. Tsuruga, E.; Takita, H.; Itoh, H.; Wakisaka, Y.; Kuboki, Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J. Biochem. 1997, 121, 317-324.
200. Noshi, T.; Yoshikawa, T.; Dohi, Y.; Ikeuchi, M.; Horiuchi, K.; Ichijima, K.; Sugimura, M.; Yonemasu, K.; Ohgushi, H. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites. Artif. Organs 2001, 25, 201-208.
201. Kraiwattanapong, C.; Boden, S.D.; Louis-Ugbo, J.; Attallah, E.; Barnes, B.; Hutton, W.C. Comparison of healos/bone marrow to infuse(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 2005, 30, 1001-1007.
202. Boden, S.D.; Martin, G.J., Jr.; Morone, M.A.; Ugbo, J.L.; Moskovitz, P.A. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 1999, 24, 1179-1185.
203. Uludag, H.; D'Augusta, D.; Palmer, R.; Timony, G.; Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 1999, 46, 193-202.
204. Rohanizadeh, R.; Chung, K. Hydroxyapatite as a carrier for bone morphogenetic protein. J. Oral Implantol. 2011, 37, 659-672.
205. Xiao, W.; Fu, H.; Rahaman, M.N.; Liu, Y.; Bal, B.S. Hollow hydroxyapatite microspheres: A novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration. Acta Biomater. 2013, 9, 8374-8383.
206. Zambuzzi, W.F.; Fernandes, G.V.; Iano, F.G.; Fernandes Mda, S.; Granjeiro, J.M.; Oliveira, R.C. Exploring anorganic bovine bone granules as osteoblast carriers for bone bioengineering: A study in rat critical-size calvarial defects. Braz. Dent. J. 2012, 23, 315-321.
207. Mitri, F.; Alves, G.; Fernandes, G.; Konig, B.; Rossi, A.J.; Granjeiro, J. Cytocompatibility of porous biphasic calcium phosphate granules with human mesenchymal cells by a multiparametric assay. Artif. Organs 2012, 36, 535-542.
208. Lomelino Rde, O.; Castro, S., II; Linhares, A.B.; Alves, G.G.; Santos, S.R.; Gameiro, V.S.; Rossi, A.M.; Granjeiro, J.M. The association of human primary bone cells with biphasic calcium phosphate (βTCP/HA 70:30) granules increases bone repair. J. Mater. Sci. Mater. Med. 2012, 23, 781-788.
209. Kamitakahara, M.; Ohtsuki, C.; Miyazaki, T. Review paper: Behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. J. Biomater. Appl. 2008, 23, 197-212.
210. Hagi, T.T.; Wu, G.; Liu, Y.; Hunziker, E.B. Cell-mediated BMP-2 liberation promotes bone formation in a mechanically unstable implant environment. Bone 2010, 46, 1322-1327.
211. Yuan, H.; De Bruijn, J.; Zhang, X.; van Blitterswijk, C.; de Groot, K. Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier. J. Mater. Sci. Mater. Med. 2001, 12, 761-766.
212. Cao, X.; Liu, C.; Chen, J. Experimental studies on the porous calcium phosphate cement combined with recombinant human bone morphogenetic protein 2 for bone defects repair. Chin. J. Reparative Reconstr. Surg. 2006, 20, 916-919. (In Chinese).
213. Edwards, R.B., 3rd; Seeherman, H.J.; Bogdanske, J.J.; Devitt, J.; Vanderby, R., Jr.; Markel, M.D. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J. Bone Jt. Surg. Am. 2004, 86-A, 1425-1438.
214. Miranda, D.A.; Blumenthal, N.M.; Sorensen, R.G.; Wozney, J.M.; Wikesjo, U.M. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J. Periodontol. 2005, 76, 210-220.
215. Barnes, B.; Boden, S.D.; Louis-Ugbo, J.; Tomak, P.R.; Park, J.S.; Park, M.S.; Minamide, A. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Spine 2005, 30, 1127-1133.
216. Saito, N.; Takaoka, K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 2003, 24, 2287-2293.
217. Saito, N.; Okada, T.; Toba, S.; Miyamoto, S.; Takaoka, K. New synthetic absorbable polymers as BMP carriers: Plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. J. Biomed. Mater. Res. 1999, 47, 104-110.
218. Saito, N.; Okada, T.; Horiuchi, H.; Ota, H.; Takahashi, J.; Murakami, N.; Nawata, M.; Kojima, S.; Nozaki, K.; Takaoka, K. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 2003, 32, 381-386.
219. Miyamoto, S.; Takaoka, K.; Okada, T.; Yoshikawa, H.; Hashimoto, J.; Suzuki, S.; Ono, K. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin. Orthop. Relat. Res. 1992, 278, 274-285.
220. Polimeni, G.; Koo, K.T.; Pringle, G.A.; Agelan, A.; Safadi, F.F.; Wikesjo, U.M. Histopathological observations of a polylactic acid-based device intended for guided bone/tissue regeneration. Clin. Implant Dent. Relat. Res. 2008, 10, 99-105.
221. Gao, T.J.; Kousinioris, N.A.; Wozney, J.M.; Winn, S.; Uludag, H. Synthetic thermoreversible polymers are compatible with osteoinductive activity of recombinant human bone morphogenetic protein 2. Tissue Eng. 2002, 8, 429-440.
222. Saito, N.; Murakami, N.; Takahashi, J.; Horiuchi, H.; Ota, H.; Kato, H.; Okada, T.; Nozaki, K.; Takaoka, K. Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins. Adv. Drug Deliv. Rev. 2005, 57, 1037-1048.
223. Saito, N.; Okada, T.; Horiuchi, H.; Murakami, N.; Takahashi, J.; Nawata, M.; Ota, H.; Nozaki, K.; Takaoka, K. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat. Biotechnol. 2001, 19, 332-335.
224. Suzuki, A.; Terai, H.; Toyoda, H.; Namikawa, T.; Yokota, Y.; Tsunoda, T.; Takaoka, K. A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: A potential treatment for infected bone defects. J. Orthop. Res. 2006, 24, 327-332.
225. Matsushita, N.; Terai, H.; Okada, T.; Nozaki, K.; Inoue, H.; Miyamoto, S.; Takaoka, K. Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant. J. Orthop. Sci. 2006, 11, 505-511.
226. Asahina, I.; Watanabe, M.; Sakurai, N.; Mori, M.; Enomoto, S. Repair of bone defect in primate mandible using a bone morphogenetic protein (BMP)-hydroxyapatite-collagen composite. J. Med. Dent. Sci. 1997, 44, 63-70.
227. Li, J.; Li, Y.; Ma, S.; Gao, Y.; Zuo, Y.; Hu, J. Enhancement of bone formation by BMP-7 transduced mscs on biomimetic nano-hydroxyapatite/polyamide composite scaffolds in repair of mandibular defects. J. Biomed. Mater. Res. A 2010, 95, 973-981.
228. Winet, H.; Hollinger, J.O. Incorporation of polylactide-polyglycolide in a cortical defect: Neoosteogenesis in a bone chamber. J. Biomed. Mater. Res. 1993, 27, 667-676.
229. Miller, R.A.; Brady, J.M.; Cutright, D.E. Degradation rates of oral resorbable implants (polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res. 1977, 11, 711-719.
230. Grayson, A.C.; Voskerician, G.; Lynn, A.; Anderson, J.M.; Cima, M.J.; Langer, R. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J. Biomater. Sci. Polym. Ed. 2004, 15, 1281-1304.
231. Peppas, N.A. Hydrogels and drug delivery. Curr. Opin. Colloid Interface Sci. 1997, 2, 531-537.
232. Hoare, T.R.; Kohane, D.S. Hydrogels in drug delivery: Progress and challenges. Polymer 2008, 49, 1993-2007.
233. Kamath, K.R.; Park, K. Biodegradable hydrogels in drug delivery. Adv. Drug Deliv. Rev. 1993, 11, 59-84.
234. Vermonden, T.; Censi, R.; Hennink, W.E. Hydrogels for protein delivery. Chem. Rev. 2012, 112, 2853-2888.
235. Tessmar, J.K.; Göpferich, A.M. Matrices and scaffolds for protein delivery in tissue engineering. Adv. Drug Deliv. Rev. 2007, 59, 274-291.
236. Fisher, J.P.; Jo, S.; Mikos, A.G.; Reddi, A.H. Thermoreversible hydrogel scaffolds for articular cartilage engineering. J. Biomed. Mater. Res. A 2004, 71, 268-274.
237. Mano, J.F.; Reis, R.L. Osteochondral defects: Present situation and tissue engineering approaches. J. Tissue Eng. Regen. Med. 2007, 1, 261-273.
238. Mano, J.F.; Silva, G.A.; Azevedo, H.S.; Malafaya, P.B.; Sousa, R.A.; Silva, S.S.; Boesel, L.F.; Oliveira, J.M.; Santos, T.C.; Marques, A.P.; et al. Natural origin biodegradable systems in tissue engineering and regenerative medicine: Present status and some moving trends. J. R. Soc. Interface 2007, 4, 999-1030.
239. Malafaya, P.B.; Gomes, M.E.; Salgado, A.J.; Reis, R.L. Polymer based scaffolds and carriers for bioactive agents from different natural origin materials. Adv. Exp. Med. Biol. 2003, 534, 201-233.
240. Gomes, M.E.; Malafaya, P.B.; Reis, R.L. Methodologies for processing biodegradable and natural origin scaffolds for bone and cartilage tissue-engineering applications. Methods Mol. Biol. 2004, 238, 65-76.
241. Saito, A.; Suzuki, Y.; Ogata, S.; Ohtsuki, C.; Tanihara, M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim. Biophys. Acta 2003, 1651, 60-67.
242. Tuzlakoglu, K.; Alves, C.M.; Mano, J.F.; Reis, R.L. Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. Macromol. Biosci. 2004, 4, 811-819.
243. Baran, E.T.; Mano, J.F.; Reis, R.L. Starch-chitosan hydrogels prepared by reductive alkylation cross-linking. J. Mater. Sci. Mater. Med. 2004, 15, 759-765.
244. Prabaharan, M.; Mano, J.F. Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 2005, 12, 41-57.
245. Hsieh, C.Y.; Hsieh, H.J.; Liu, H.C.; Wang, D.M.; Hou, L.T. Fabrication and release behavior of a novel freeze-gelled chitosan/gamma-PGA scaffold as a carrier for rhBMP-2. Dent. Mater. 2006, 22, 622-629.
246. Hattori, T. Experimental investigations of osteogenesis and chondrogenesis by implant of BMP-fibrin glue mixture. Nihon Seikeigeka Gakkai Zasshi 1990, 64, 824-834.
247. Han, D.K.; Kim, C.S.; Jung, U.W.; Chai, J.K.; Choi, S.H.; Kim, C.K.; Cho, K.S. Effect of a fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J. Periodontol. 2005, 76, 2216-2222.
248. Ren, W.; Yang, L.; Dong, S. The effects of the complex of rhBMP2 and fibrin sealant on dental pulp. Chin. J. Stomatol. 2000, 35, 18-20. (In Chinese).
249. Osathanon, T.; Linnes, M.L.; Rajachar, R.M.; Ratner, B.D.; Somerman, M.J.; Giachelli, C.M. Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials 2008, 29, 4091-4099.
250. Hubbell, J.A. Matrix-bound growth factors in tissue repair. Swiss Med. Wkly. 2006, 136, 387-391.
251. Kim, H.D.; Valentini, R.F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J. Biomed. Mater. Res. 2002, 59, 573-584.
252. Wikesjo, U.M.; Lim, W.H.; Thomson, R.C.; Cook, A.D.; Wozney, J.M.; Hardwick, W.R. Periodontal repair in dogs: Evaluation of a bioabsorbable space-providing macroporous membrane with recombinant human bone morphogenetic protein-2. J. Periodontol. 2003, 74, 635-647.
253. Meinel, L.; Fajardo, R.; Hofmann, S.; Langer, R.; Chen, J.; Snyder, B.; Vunjak-Novakovic, G.; Kaplan, D. Silk implants for the healing of critical size bone defects. Bone 2005, 37, 688-698.
254. Kirker-Head, C.A. Potential applications and delivery strategies for bone morphogenetic proteins. Adv. Drug Deliv. Rev. 2000, 43, 65-92.
255. Taylor, P.; Allen, S.; Dreger, S.; Yacoub, M. Human cardiac valve interstitial cells in collagen sponge: A biological three-dimensional matrix for tissue engineering. J. Heart Valve Dis. 2002, 11, 298-306.
256. Wallace, D.G.; Rosenblatt, J. Collagen gel systems for sustained delivery and tissue engineering. Adv. Drug Deliv. Rev. 2003, 55, 1631-1649.
257. Kim, C.S.; Kim, J.I.; Kim, J.; Choi, S.H.; Chai, J.K.; Kim, C.K.; Cho, K.S. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005, 26, 2501-2507.
258. Geiger, M.; Li, R.H.; Friess, W. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 2003, 55, 1613-1629.
259. Visser, R.; Arrabal, P.M.; Becerra, J.; Rinas, U.; Cifuentes, M. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. Biomaterials 2009, 30, 2032-2037.
260. Wei, G.; Jin, Q.; Giannobile, W.V.; Ma, P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007, 28, 2087-2096.
261. MacNeil, S. Biomaterials for tissue engineering of skin. Mater. Today 2008, 11, 26-35.
262. Angele, P.; Abke, J.; Kujat, R.; Faltermeier, H.; Schumann, D.; Nerlich, M.; Kinner, B.; Englert, C.; Ruszczak, Z.; Mehrl, R. Influence of different collagen species on physico-chemical properties of crosslinked collagen matrices. Biomaterials 2004, 25, 2831-2841.
263. Sailer, H.F. A new method of inserting endosseous implants in totally atrophic maxillae. J. Cranio-Maxillo-Fac. Surg. 1989, 17, 299-305.
264. Ong, J.L.; Cardenas, H.L.; Cavin, R.; Carnes, D.L., Jr. Osteoblast responses to BMP-2-treated titanium in vitro. Int. J. Oral Maxillofac. Implant. 1997, 12, 649-654.
265. Piskounova, S.; Forsgren, J.; Brohede, U.; Engqvist, H.; Stromme, M. In vitro characterization of bioactive titanium dioxide/hydroxyapatite surfaces functionalized with BMP-2. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 91, 780-787.
266. Bessho, K.; Carnes, D.L.; Cavin, R.; Chen, H.Y.; Ong, J.L. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin. Oral Implant. Res. 1999, 10, 212-218.
267. Ishibe, T.; Goto, T.; Kodama, T.; Miyazaki, T.; Kobayashi, S.; Takahashi, T. Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009, 108, 867-875.
268. Kim, S.H.; Park, J.K.; Hong, K.S.; Jung, H.S.; Seo, Y.K. Immobilization of BMP-2 on a nano-hydroxyapatite-coated titanium surface using a chitosan calcium chelating agent. Int. J. Artif. Organs 2013, 36, 506-517.
269. Kim, S.E.; Yun, Y.P.; Lee, J.Y.; Shim, J.S.; Park, K.; Huh, J.B. Co-delivery of platelet-derived growth factor (PDGF-BB) and bone morphogenic protein (BMP-2) coated onto heparinized titanium for improving osteoblast function and osteointegration. J. Tissue Eng. Regen. Med. 2013, doi:10.1002/term.1668.
270. Kim, S.E.; Kim, C.S.; Yun, Y.P.; Yang, D.H.; Park, K.; Kim, S.E.; Jeong, C.M.; Huh, J.B. Improving osteoblast functions and bone formation upon BMP-2 immobilization on titanium modified with heparin. Carbohydr. Polym. 2014, 114, 123-132.
271. Kim, S.E.; Song, S.H.; Yun, Y.P.; Choi, B.J.; Kwon, I.K.; Bae, M.S.; Moon, H.J.; Kwon, Y.D. The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 2011, 32, 366-373.
272. Lee, S.C.; Shea, M.; Battle, M.A.; Kozitza, K.; Ron, E.; Turek, T.; Schaub, R.G.; Hayes, W.C. Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix. J. Biomed. Mater. Res. 1994, 28, 1149-1156.
273. Chen, F.; Wu, Z.; Wang, Q.; Wu, H.; Zhang, Y.; Nie, X.; Jin, Y. Preparation and biological characteristics of recombinant human bone morphogenetic protein-2-loaded dextran-co-gelatin hydrogel microspheres, in vitro and in vivo studies. Pharmacology 2005, 75, 133-144.
274. Chen, F.; Wu, Z.; Jin, Y.; Wang, Q.; Du, Y.; Wang, G. Preparation and property of recombinant human bone morphogenetic protein-2 loaded hydrogel nanospheres and their biological effects on the proliferation and differentiation of bone mesenchymal stem cells. Shanghai J. Stomatol. 2005, 14, 485.
275. Chen, F.-M.; Zhao, Y.-M.; Sun, H.-H.; Jin, T.; Wang, Q.-T.; Zhou, W.; Wu, Z.-F.; Jin, Y. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: Formulation and characteristics. J. Control. Release 2007, 118, 65-77.
276. Cao, L.; Wang, J.; Hou, J.; Xing, W.; Liu, C. Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2. Biomaterials 2014, 35, 684-698.
277. Yang, K.; Cao, W.; Hao, X.; Xue, X.; Zhao, J.; Liu, J.; Zhao, Y.; Meng, J.; Sun, B.; Zhang, J.; et al. Metallofullerene nanoparticles promote osteogenic differentiation of bone marrow stromal cells through BMP signaling pathway. Nanoscale 2013, 5, 1205-1212.
278. Wang, Y.; Mostafa, N.Z.; Hsu, C.Y.; Rose, L.; Kucharki, C.; Yan, J.; Jiang, H.; Uludag, H. Modification of human bmsc with nanoparticles of polymeric biomaterials and plasmid DNA for BMP-2 secretion. J. Surg. Res. 2013, 183, 8-17.
279. Kim, T.H.; Kim, M.; Eltohamy, M.; Yun, Y.R.; Jang, J.H.; Kim, H.W. Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells. J. Biomed. Mater. Res. A 2013, 101, 1651-1660.
280. Park, K.H.; Kim, H.; Moon, S.; Na, K. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. J. Biosci. Bioeng. 2009, 108, 530-537.
281. Zhang, S.; Kucharski, C.; Doschak, M.R.; Sebald, W.; Uludag, H. Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. Biomaterials 2010, 31, 952-963.
282. Zhang, S.; Wang, G.; Lin, X.; Chatzinikolaidou, M.; Jennissen, H.P.; Laub, M.; Uludag, H. Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery. Biotechnol. Prog. 2008, 24, 945-956.
283. Zhang, S.; Doschak, M.R.; Uludag, H. Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles. Biomaterials 2009, 30, 5143-5155.
284. Kim, K.; Fisher, J.P. Nanoparticle technology in bone tissue engineering. J. Drug Target 2007, 15, 241-252.
285. Cook, S.D.; Baffes, G.C.; Wolfe, M.W.; Sampath, T.K.; Rueger, D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. Relat. Res. 1994, 301, 302-312.
286. Cook, S.D.; Salkeld, S.L.; Rueger, D.C. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites. J. Oral Implantol. 1995, 21, 281-289.
287. Sigurdsson, T.; Nygaard, L.; Tatakis, D.; Fu, E.; Turek, T.; Jin, L.; Wozney, J.; Wikesjö, U. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int. J. Periodontics Restorative Dent. 1996, 16, 524-537.
288. Sigurdsson, T.J.; Lee, M.B.; Kubota, K.; Turek, T.J.; Wozney, J.M.; Wikesjö, U.M. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J. Periodontol. 1995, 66, 131-138.
289. Wikesjö, U.M.; Sorensen, R.G.; Kinoshita, A.; Jian Li, X.; Wozney, J.M. Periodontal repair in dogs: Effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment. J. Clin. Periodontol. 2004, 31, 662-670.
290. Saito, E.; Saito, A.; Kawanami, M. Favorable healing following space creation in rhBMP-2-induced periodontal regeneration of horizontal circumferential defects in dogs with experimental periodontitis. J. Periodontol. 2003, 74, 1808-1815.
291. Jovanovic, S.A.; Hunt, D.R.; Bernard, G.W.; Spiekermann, H.; Wozney, J.M.; Wikesjö, U.M. Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin. Oral Implants Res. 2007, 18, 224-230.
292. Selvig, K.A.; Sorensen, R.G.; Wozney, J.M.; Wikesjö, U.M. Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J. Periodontol. 2002, 73, 1020-1029.
293. Urist, M.R.; Iwata, H.; Strates, B.S. Bone morphogenetic protein and proteinase in the guinea pig. Clin. Orthop. Relat. Res. 1972, 85, 275-290.
294. Hu, W.; Ye, Y.; Wang, J.; Zhang, W.; Chen, A.; Guo, F. Bone morphogenetic proteins induce rabbit bone marrow-derived mesenchyme stem cells to differentiate into osteoblasts via BMP signals pathway. Artif. Cells Nanomed. Biotechnol. 2013, 41, 249-254.
295. Spicer, P.P.; Kretlow, J.D.; Young, S.; Jansen, J.A.; Kasper, F.K.; Mikos, A.G. Evaluation of bone regeneration using the rat critical size calvarial defect. Nat. Protoc. 2012, 7, 1918-1929.
296. Turgeman, G.; Zilberman, Y.; Zhou, S.; Kelly, P.; Moutsatsos, I.K.; Kharode, Y.P.; Borella, L.E.; Bex, F.J.; Komm, B.S.; Bodine, P.V.; et al. Systemically administered rhBMP-2 promotes msc activity and reverses bone and cartilage loss in osteopenic mice. J. Cell. Biochem. 2002, 86, 461-474.
297. Marden, L.J.; Hollinger, J.O.; Chaudhari, A.; Turek, T.; Schaub, R.G.; Ron, E. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J. Biomed. Mater. Res. 1994, 28, 1127-1138.
298. Yasko, A.W.; Lane, J.M.; Fellinger, E.J.; Rosen, V.; Wozney, J.M.; Wang, E.A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J. Bone Jt. Surg. Am. 1992, 74, 659-670.
299. Kirker-Head, C.A.; Gerhart, T.N.; Schelling, S.H.; Hennig, G.E.; Wang, E.; Holtrop, M.E. Long-term healing of bone using recombinant human bone morphogenetic protein 2. Clin. Orthop. Relat. Res. 1995, 318, 222-230.
300. Toriumi, D.M.; Kotler, H.S.; Luxenberg, D.P.; Holtrop, M.E.; Wang, E.A. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch. Otolaryngol. Head Neck Surg. 1991, 117, 1101-1112.
301. Cook, S.D.; Baffes, G.C.; Wolfe, M.W.; Sampath, T.K.; Rueger, D.C.; Whitecloud, T.S., 3rd. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Jt. Surg. Am. 1994, 76, 827-838.
302. Ripamonti, U.; van den Heever, B.; Sampath, T.K.; Tucker, M.M.; Rueger, D.C.; Reddi, A.H. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 1996, 13, 273-289.
303. Margolin, M.D.; Cogan, A.G.; Taylor, M.; Buck, D.; McAllister, T.N.; Toth, C.; McAllister, B.S. Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. J. Periodontol. 1998, 69, 911-919.
304. Den Boer, F.C.; Bramer, J.A.; Blokhuis, T.J.; van Soest, E.J.; Jenner, J.M.; Patka, P.; Bakker, F.C.; Burger, E.H.; Haarman, H.J. Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture. Bone 2002, 31, 158-164.
305. Mizumoto, Y.; Moseley, T.; Drews, M.; Cooper, V.N., 3rd; Reddi, A.H. Acceleration of regenerate ossification during distraction osteogenesis with recombinant human bone morphogenetic protein-7. J. Bone Jt. Surg. Am. 2003, 85, 124-130.
306. Bostrom, M.P.; Saleh, K.J.; Einhorn, T.A. Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop. Clin. N. Am. 1999, 30, 647-658.
307. Bostrom, M.P. Expression of bone morphogenetic proteins in fracture healing. Clin. Orthop. Relat. Res. 1998, 355, S116-S123.
308. Bax, B.E.; Wozney, J.M.; Ashhurst, D.E. Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif. Tissue Int. 1999, 65, 83-89.
309. Herford, A.S.; Boyne, P.J. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J. Oral Maxillofac. Surg. 2008, 66, 616-624.
310. Sweeny, L.; Lancaster, W.P.; Dean, N.R.; Magnuson, J.S.; Carroll, W.R.; Louis, P.J.; Rosenthal, E.L. Use of recombinant bone morphogenetic protein 2 in free flap reconstruction for osteonecrosis of the mandible. J. Oral Maxillofac. Surg. 2012, 70, 1991-1996.
311. Govender, S.; Csimma, C.; Genant, H.K.; Valentin-Opran, A.; Amit, Y.; Arbel, R.; Aro, H.; Atar, D.; Bishay, M.; Borner, M.G.; et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Jt. Surg. Am. 2002, 84, 2123-2134.
312. Tressler, M.A.; Richards, J.E.; Sofianos, D.; Comrie, F.K.; Kregor, P.J.; Obremskey, W.T. Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion. Orthopedics 2011, 34, e877-e884.
313. Bibbo, C.; Patel, D.V.; Haskell, M.D. Recombinant bone morphogenetic protein-2 (rhBMP-2) in high-risk ankle and hindfoot fusions. Foot Ankle Int. 2009, 30, 597-603.
314. Moghaddam, A.; Elleser, C.; Biglari, B.; Wentzensen, A.; Zimmermann, G. Clinical application of BMP 7 in long bone non-unions. Arch. Orthop. Trauma Surg. 2010, 130, 71-76.
315. Dohin, B.; Fassier, F.; Hamdy, R. Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): Early experience. Clin. Orthop. Relat. Res. 2009, 467, 3230-3238.
316. Moghaddam-Alvandi, A.; Zimmermann, G.; Büchler, A.; Elleser, C.; Biglari, B.; Grützner, P.; Wölfl, C. Results of nonunion treatment with bone morphogenetic protein 7 (BMP-7). Unfallchirurg 2012, 115, 518-526.
317. Nicodemo, A.; Capella, M.; Deregibus, M.; Massè, A. Nonunion of a sacral fracture refractory to bone grafting: Internal fixation and osteogenic protein-1 (BMP-7) application. Musculoskelet. Surg. 2011, 95, 157-161.
318. Friedlaender, G.E.; Perry, C.R.; Cole, J.D.; Cook, S.D.; Cierny, G.; Muschler, G.F.; Zych, G.A.; Calhoun, J.H.; LaForte, A.J.; Yin, S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Jt. Surg. Am. 2001, 83, S151-S158.
319. McKee, M.; Schemitsch, E.; Waddell, J.; Kreder, H.; Stephen, D.; Leighton, R.; Buckley, R.; Powell, J.; Wild, L.; Blachut, P. The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: Results of a multi-center, prospective, randomized clinical trial. In Proceedings of the 18th Annual Meeting of the Orthopaedic Trauma Association, Toronto, ON, Canada, 11-13 October 2002; pp. 11-13.
320. Ristiniemi, J.; Flinkkilä, T.; Hyvönen, P.; Lakovaara, M.; Pakarinen, H.; Jalovaara, P. rhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J. Bone Jt. Surg. Br. Vol. 2007, 89, 265-272.
321. Bilic, R.; Simic, P.; Jelic, M.; Stern-Padovan, R.; Dodig, D.; van Meerdervoort, H.P.; Martinovic, S.; Ivankovic, D.; Pecina, M.; Vukicevic, S. Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis. Int. Orthop. 2006, 30, 128-134.
322. Bong, M.R.; Capla, E.L.; Egol, K.A.; Sorkin, A.T.; Distefano, M.; Buckle, R.; Chandler, R.W.; Koval, K.J. Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions. Bull. Hosp. Jt. Dis. 2005, 63, 20.
323. McKee, M.; Schemitsch, E.; Waddell, J.; Wild, L. The treatment of long bone nonunion with rhBMP: Results of a prospective pilot study. In Proceedings of the American Academy of Orthopaedic Surgeons 71st Annual Meeting, San Francisco, CA, USA, 10-14 March 2004; pp. 10-14.
324. Simmonds, M.C.; Brown, J.V.; Heirs, M.K.; Higgins, J.P.; Mannion, R.J.; Rodgers, M.A.; Stewart, L.A. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: A meta-analysis of individual-participant data. Ann. Intern. Med. 2013, 158, 877-889.
325. Fu, R.; Selph, S.; McDonagh, M.; Peterson, K.; Tiwari, A.; Chou, R.; Helfand, M. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: A systematic review and meta-analysis. Ann. Intern. Med. 2013, 158, 890-902.
326. Carragee, E.J.; Hurwitz, E.L.; Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J. 2011, 11, 471-491.
327. Hustedt, J.W.; Blizzard, D.J. The controversy surrounding bone morphogenetic proteins in the spine: A review of current research. Yale J. Biol. Med. 2014, 87, 549-561.
328. Carter, S.; Braem, K.; Lories, R.J. The role of bone morphogenetic proteins in ankylosing spondylitis. Ther. Adv. Musculoskelet. Dis. 2012, 4, 293-299.
329. Urist, M.R. Bone: Formation by autoinduction. Science 1965, 150, 893-899.
330. Hadjiargyrou, M.; Lombardo, F.; Zhao, S.; Ahrens, W.; Joo, J.; Ahn, H.; Jurman, M.; White, D.W.; Rubin, C.T. Transcriptional profiling of bone regeneration insight into the molecular complexity of wound repair. J. Biol. Chem. 2002, 277, 30177-30182.
331. White, A.P.; Vaccaro, A.R.; Hall, J.A.; Whang, P.G.; Friel, B.C.; McKee, M.D. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int. Orthop. 2007, 31, 735-741.